ArticleBone marrow transplantation2025

Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: initiative for standardizing guidelines.

Aqeeb Ur Rehman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.